Advertisements

We Made New Cancer Drug For Rich White People Not (Ick) Poor Indian People, Pharma Giant CEO Actually Says Out Loud


2012 The Awakening

by Abby Zimet

Indian cancer patients camped outside the hospital where they are being treated

Right up there in the annals of multinational corporations doing heinous things in the name of obscene profits comes the response of the German-based Bayer to India’s unprecedented ending of the pharmaceutical giant’s monopoly for a new, insanely expensive anti-cancer drug Nexavar – a brave move that allows a small Indian drug company to make a generic version of the drug that regular poor sick people can actually afford. One year of treatment with Nexavar, used largely in liver and kidney cancer cases, costs $96,000 in the U.S. and $69,000 in India, or 41 times the per capita income; India’s Natco Ltd. made it for $177 a year. Outraged Bayer officials charged the Indian action allowing poor people to have their fancy drug was “essentially theft” and they will damn sure

View original post 73 more words

Advertisements

Categories: Home

Author:General Maddox

Real News Australia was founded in 2012 and is Australia's leading alternative news site featuring; open source journalism, current news articles that actually matter, opinionated editorials, shared news items from Australia and around the world, documentary films & video clips. We are dedicated to talking about real issues, health news, world events, political events and deciphering the main stream media garbage in order to break the cycle of propaganda. Remember: "Journalism is printing what someone else does not want printed. Everything else is public relations." - George Orwell. Please share anything you feel is worth sharing and subscribe to our emails. This operation is run on a shoestring budget so any contributions are well received.

Subscribe

Subscribe to our RSS feed and social profiles to receive updates.

%d bloggers like this: